Comprehensive evaluation of hypertrophic cardiomyopathy: European Journal of Heart Failure expert consensus document
European Journal of Heart Failure · 2026
DOI: 10.1093/ejhf/xuag035 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Heart Failure, 2026. Verfasst von Pieter Martens und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ziekenhuis Oost Limburg, synapspark 1, 3600 Genk, Belgium - University Hasselt, 3500 Hasselt, Belgium. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Death, Sudden, Cardiac, Heart Failure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease and a leading cause of heart failure and sudden cardiac death (SCD) in young adults. Given its complex pathophysiology, phenotypic diversity, and rapidly evolving therapeutic landscape, a structured and multidisciplinary approach to care is essential. This manuscript outlines a six-pillar framework to standardize and optimize evaluation and management of HCM. The proposed model organizes HCM care into six key domains. (i) Establishing the correct diagnosis, which requires differentiation between sarcomeric HCM and phenocopies such as amyloidosis, Fabry, or mitochondrial disease, using multimodal imaging and genetic testing. (ii) Establish presence of symptoms and of left ventricular outflow tract obstruction (LVOTO), which is central to symptom evaluation, prognostication, and treatment. Dynamic assessment with exercise echocardiography when required is essential to guide management, including pharmacotherapy or septal reduction therapy. (iii) Risk stratification for SCD integrates risk scores with adjunctive imaging data to support patient-centred implantable cardioverter defibrillator decisions. (iv) Genetic evaluation and family management enable cascade testing, early detection, and counselling. (v) Management of comorbidities—including atrial fibrillation, hypertension, obesity, and sleep-disordered breathing—is integral to holistic care and symptom control. (vi) Education and lifestyle guidance focus on safe sport participation, avoidance of dehydration and vasodilators, and reproductive counselling within a multidisciplinary setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ziekenhuis Oost Limburg, synapspark 1, 3600 Genk, Belgium - University Hasselt, 3500 Hasselt, Belgium.
- Department of cardiology, Meyer Children's Hospital IRCCS, Florence, Italy.
- Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, CIBERCV, Majadahonda, Spain.
- Department Inherited Cardiomyopathy,Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
- Department of Cardiology, Thoraxcenter, Cardiovascular Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
- Hypertrophic Cardiomyopathy Center, Heart Vascular Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.
ORCID-Profile: Pieter Martens, Pablo Garcia-Pavia, Michelle Michels
Zitieren
APA
Martens, P., Olivotto, I., Garcia-Pavia, P., Michels, M., Desai, M. Y., & Mullens, W. (2026). Comprehensive evaluation of hypertrophic cardiomyopathy: European Journal of Heart Failure expert consensus document. European Journal of Heart Failure. https://doi.org/10.1093/ejhf/xuag035
Vancouver
Martens P, Olivotto I, Garcia-Pavia P, Michels M, Desai MY, Mullens W. Comprehensive evaluation of hypertrophic cardiomyopathy: European Journal of Heart Failure expert consensus document. European Journal of Heart Failure. 2026. doi:10.1093/ejhf/xuag035
BibTeX
@article{Martens2026,
author = {Martens, Pieter and Olivotto, Iacopo and Garcia-Pavia, Pablo and Michels, Michelle and Desai, Milind Y and Mullens, Wilfried},
title = {Comprehensive evaluation of hypertrophic cardiomyopathy: European Journal of Heart Failure expert consensus document},
journal = {European Journal of Heart Failure},
year = {2026},
doi = {10.1093/ejhf/xuag035}
}
EUVIMED